Persistent URL of this record https://hdl.handle.net/1887/116782
In Collections
This item can be found in the following collections:
![Golimumab, a New, Human, TNF-alpha Antibody Administered Subcutaneously Every 4 Weeks, in Ankylosing Spondylitis: 104-Week Efficacy and Safety Results of the Randomized, Placebo-Controlled GO-RAISE Study](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Golimumab, a New, Human, TNF-alpha Antibody Administered Subcutaneously Every 4 Weeks, in Ankylosing Spondylitis: 104-Week Efficacy and Safety Results of the Randomized, Placebo-Controlled GO-RAISE Study
- All authors
- Braun, J.; Heijde, D. van der; Deodhar, A.; Diekman, L.; Sieper, J.; Kim, S.I.; Beutler, A.; Mack, M.; Xu, S.; Zrubek, J.; Hsu, B.; Inman, R.
- Date
- 2010-06-30
- Title of host publication
- Journal of Rheumatology
- Volume
- 37
- Issue
- 6
- Pages
- 1323 - 1323